Gregory Zante
Director Financiero/CFO en VIKING THERAPEUTICS, INC. .
Fortuna: 12 M $ al 30/04/2024
Cargos activos de Gregory Zante
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
VIKING THERAPEUTICS, INC. | Director Financiero/CFO | 04/01/2021 | - |
Contacto de Relaciones con Inversores | - | - | |
Comptroller/Controller/Auditor | 15/02/2021 | - | |
Director de Operaciones | 01/12/2016 | 01/08/2019 | |
Public Communications Contact | 05/01/2016 | - | |
Corporate Officer/Principal | 01/08/2019 | 04/01/2021 |
Historial de carrera de Gregory Zante
Antiguos cargos conocidos de Gregory Zante.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Director Financiero/CFO | 01/01/2013 | 01/01/2016 |
SANGAMO THERAPEUTICS, INC. | Director Administrativo | 01/08/2003 | 01/06/2013 |
Calyx Therapeutics, Inc. | Director Administrativo | 01/12/2001 | - |
Director Financiero/CFO | 01/12/2001 | - | |
Matrix Pharmaceutical, Inc.
Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Matrix Pharmaceutical, Inc. is a company that researches and develops pharmaceutical products. The company is based in Fremont, CA. The company was founded in 1985 by Dennis M. Brown. Matrix Pharmaceutical was acquired by Chiron Corp. on February 19, 2002 for $58.63 million. | Corporate Officer/Principal | 01/10/1995 | 01/12/2001 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/10/1993 | 01/11/1995 |
Formación de Gregory Zante.
University of California, Los Angeles | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Reino Unido | 2 |
Operativa
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 3 |
Chief Administrative Officer | 2 |
Sectorial
Health Technology | 5 |
Consumer Services | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
VIKING THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Calyx Therapeutics, Inc. | |
Matrix Pharmaceutical, Inc.
Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Matrix Pharmaceutical, Inc. is a company that researches and develops pharmaceutical products. The company is based in Fremont, CA. The company was founded in 1985 by Dennis M. Brown. Matrix Pharmaceutical was acquired by Chiron Corp. on February 19, 2002 for $58.63 million. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Gregory Zante
- Experiencia